Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: Comparison with historical experience

Hagop M. Kantarjian, Susan O'Brien, Xuelin Huang, Guillermo Garcia-Manero, Farhad Ravandi, Jorge Cortes, Jianqin Shan, Jan Davisson, Carlos E. Bueso-Ramos, Jean Pierre Issa

Research output: Contribution to journal › Article › peer-review

166 Scopus citations

Fingerprint

Dive into the research topics of 'Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: Comparison with historical experience'. Together they form a unique fingerprint.

Medicine & Life Sciences